Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity

Background: Coronavirus disease of 2019 (COVID-19) is associated with a prothrombotic state and a high incidence of thrombotic event(s) (TE).Objectives: To study platelet reactivity in hospitalized COVID-19 patients and determine a possible association with the clinical outcomes thrombosis and all-c...

Descripció completa

Dades bibliogràfiques

Autors principals:	Chantal C. Clark, Bernard N. Jukema, Arjan D. Barendrecht, Judith S. Spanjaard, Nikita K. N. Jorritsma, Simone Smits, Steven de Maat, Cor W. Seinen, Sandra Verhoef, Naomi M. J. Parr, Silvie A. E. Sebastian, Arnold C. Koekman, Annet C. W. van Wesel, Harriet M. R. van Goor, Roy Spijkerman, Suzanne H. Bongers, Erhard van der Vries, Stefan Nierkens, Marianne Boes, Leo Koenderman, Karin A. H. Kaasjager, Coen Maas
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2021-04-01
Col·lecció:	Frontiers in Medicine
Matèries:	COVID-19 platelets SARS-CoV-2 thrombosis thrombotic event pulmonary thrombosis
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fmed.2021.650129/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!